A discovery by Washington State University scientist Dan Rodgers and collaborator Paul Gregorevic could save millions of people suffering from muscle wasting disease.
The result of the team’s four-year project is a novel gene therapeutic approach. The work was published (http://stm.sciencemag.org/content/8/348/348ra98) July 20 in Science Translational Medicine, a journal of the American Association for the Advancement of Science.
“Chronic disease affects more than half of the world’s population,” said Rodgers, professor of animal sciences (https://ansci.wsu.edu/people/faculty/dan-rodgers/) and director of the Washington Center for Muscle Biology (http://wcmb.wsu.edu/). “Most of those diseases are accompanied by muscle wasting.
“It occurs with chronic infection, muscular dystrophy, malnutrition and old age,” he said. “About half the people who die from cancer are actually dying from muscle wasting and there’s not one single therapy out there that addresses it.
Family history inspires search for treatment
“I have a strong motivation to do something about this, to do more than simply publish results,” said Rodgers, who teamed with Gregorevic of Baker IDI Heart and Diabetes Institute in Australia (https://www.bakeridi.edu.au/). “My father died from cachexia,” the wasting disease caused by cancer, “and my nephew has Duchenne muscular dystrophy, an incurable, fatal disease that could claim his life in his teens.
“Others have tried and failed to develop treatments for muscle wasting,” Rodgers said, “and some drugs have even caused serious safety problems. Our targeted approach only affects muscle and completely avoids these problems, which is why we think we have a solution.”
In the paper, lead author Catherine Winbanks, a postdoctoral fellow of Gregorevic, details how researchers built muscle in healthy mice and prevented the loss of skeletal and heart muscle in mice with tumors.
Hormone’s muscle-wasting effect blocked
In cachexia, tumors secrete hormones that cause muscle deterioration; in effect, the body eats its own muscles, causing weakness, frailty and fatigue.
“What kills a lot of people isn’t the loss of skeletal muscle but heart muscle,” said Rodgers. “The heart literally shrinks, causing heart failure.”
Researchers have long sought to stop this process, but failed to find a safe way. That’s because the hormones that cause wasting – in particular, a naturally occurring hormone called myostatin – play important roles elsewhere in the body.
Rodgers and Gregorevic needed a way to stop myostatin, but only in muscles. Their solution: an adeno-associated virus – a benign virus that specifically targets heart and skeletal muscle.
The virus delivers a small piece of DNA – a signaling protein called Smad7 – into muscle cells. Smad7 then blocks two signaling proteins called Smad2 and Smad3, which are activated by myostatin and other muscle-wasting hormones. By blocking those signals, Smad7 stops the breakdown of muscles.
“Smad7 is the body’s natural break and, by inhibiting the inhibitor, you build muscle,” Rodgers said.
For cachexia patients, such a therapy could massively increase their chances of survival.
“Instead of having one year to fight cancer, you’d have 10 or 15,” Rodgers said.
Startup works to develop commercial drug
In 2015, Rodgers launched AAVogen, a company that will develop this discovery into a commercial drug, AVGN7.
He has been working with Norman Ong, a technology licensing associate at WSU’s Office of Commercialization, on patents, startup funding and recruitment for AAVogen. Using the funds from WSU’s commercial gap fund award, Rodgers’ lab will determine the minimum effective dose for AVGN7.
“We want to turn WSU discoveries into real-world uses that benefit the public,” said Ong. “Dan is a very busy scientist, so we’re proud to help him and AAVogen connect with the right people.”
“I formed this company for one purpose: to move the science into society, to see it applied,” Rodgers said. “WSU’s Office of Commercialization has been instrumental and invaluable to this endeavor.
“Now we have a company with the potential to save a lot of lives,” he said.
The Latest on: Muscle wasting
via Google News
The Latest on: Muscle wasting
- How the Chicago Bears Can Avoid Wasting Strong Starton October 10, 2020 at 9:19 am
The Chicago Bears have started 4-0 and have a 77% chance of making the playoffs with this record but there are three problems they need to address to be confident they've maximized their chances for ...
- Erase My Back Pain Review: Back to Life Healthy Back Systemon October 9, 2020 at 6:13 pm
Healthy Back System Healthy Back System is a cost-effective holistic treatment solution designed to alleviate a number of back pain problems that most people face regularly. Emily put together the Bac ...
- New research provides fresh hope for children suffering from rare muscle diseaseson October 9, 2020 at 6:51 am
Results of an international study published today in Autophagy and led by researchers from Monash University, School of Biological Sciences, provides renewed hope for children suffering from a ...
- Providing new hope for children suffering from rare muscle diseaseson October 9, 2020 at 5:12 am
Stephen Greenspan and Laura Zah were devastated when they learned their son Alexander had a rare genetic mutation, which causes a deadly neuromuscular disease with no known treatment or cure.
- Achilles Tendon Repair: Little Benefit to Early Mobilizationon October 8, 2020 at 7:37 am
Early functional mobilization (EFM) does not appear to offer any real benefit after surgical repair of an Achilles tendon rupture, according to a new study. The findings from “Changes in Tendon ...
- Six year-old girl with muscle-wasting disease walks 300kmon October 2, 2020 at 8:35 am
Watson, who has a muscle wasting disease that means she will lose the use of her legs, has completed a gruelling ‘marathon a day’ challenge to raise funds for Muscular Dystrophy UK. Carmela’s ...
- East Malling dad walking from London Bridge to Canterbury Cathedral for son who has muscle wasting conditionon October 2, 2020 at 6:15 am
A group are raising money to make sure a little boy, who has a severe muscle degeneration disorder, has the best life possible.
- Scholar Rock Presents Data for SRK-015 at the World Muscle Society 2020 Virtual Congresson September 30, 2020 at 4:30 am
Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced two poster ...
- Spinal Muscular Atrophy Treatment Market To Be Propelled By Rising Prevalence of Genetic Diseases and Growing R&D Concerning Its Treatmenton September 30, 2020 at 4:07 am
Research Nester published a report titled "Spinal Muscular Atrophy Treatment Market: Global Demand Analysis & Opportunity Outlook 2028" which delivers a detailed overview of the Spinal muscular ...
- Spinal Muscular Atrophy Pipeline Market Global Insight, Key Players, collaborations, Licensing, Acquisition, Deal Value Trends Report 2020on September 29, 2020 at 12:15 pm
Pipeline Insight, 2020,report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Spinal Muscular Atrophy Pipeline landscape. It covers the pipeline drug profiles, including ...
via Bing News